Related Experiment Video
Updated: May 1, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
26.7K
[Diarrhea associated with Clostridium difficile in the elderly: new perspectives]
1Sección de Geriatría, Hospital Universitario de Guadalajara, Sescam, Guadalajara, España.
Revista Espanola De Geriatria Y Gerontologia
|April 2, 2014
Summary
Clostridium difficile infection (CDI) is a leading cause of hospital-acquired gastrointestinal disease, particularly in the elderly. New treatments like fidaxomicin and fecal transplants show promise for managing recurrent CDI.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Geriatrics
Background:
- Clostridium difficile infection (CDI) is a primary cause of hospital-acquired gastrointestinal disease.
- Elderly individuals face higher CDI risk due to comorbidities, healthcare exposure, immunosenescence, and medication use (antibiotics, antacids).
- Advancements in diagnostic techniques have contributed to increased CDI detection rates.
Purpose of the Study:
- To review the current landscape of Clostridium difficile infection in the elderly.
- To discuss updated diagnostic approaches and treatment strategies for CDI.
- To highlight novel therapeutic options for managing recurrent CDI.
Main Methods:
- Literature review of recent studies and clinical guidelines on Clostridium difficile infection.
- Analysis of risk factors and diagnostic improvements in the elderly population.
- Evaluation of emerging treatment modalities for CDI.
Main Results:
- CDI prevalence is elevated in the elderly due to multiple risk factors.
- Improved diagnostics are enhancing CDI case identification.
- New treatments, including fidaxomicin and fecal microbiota transplantation, demonstrate efficacy in controlling recurrent CDI.
Conclusions:
- Stratified treatment approaches based on clinical severity are recommended for CDI.
- Novel therapies offer improved outcomes for recurrent Clostridium difficile infections.
- Continued research and guideline updates are crucial for optimal CDI management in vulnerable populations.
Related Concept Videos
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
602
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
602
01:17Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
01:17Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
01:30Development of Human Microbiota
61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
989
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
854
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
854